Latest Mass Tort News and Updates

The U.S. Food & Drug Administration (FDA) has finally given a go to Perrigo Company Plc., to market a store-brand equivalent of Nexium 24HR which is an OTC version of Nexium used to treat heartburns. Owing to the fact…

Taxotere, a chemotherapy drug approved by the FDA for treating cancer in 1996, is currently the subject of several lawsuits in multiple states as the announcement hit the news that the first lawsuit filed under MDL…

In spite of a list of side effects linked to Onglyza, there is only some success or positive movement at the plaintiff's end. Last year, 14 of them had their claims dismissed by a federal judge in California who granted the defendant AstraZeneca'…

Invokana lawsuits have shown further movement in the court proceedings with the approval coming forth for the Plaintiff Fact Sheets along with its protocols details by the U.S. District Court, District of New Jersey.…

As the PPI case filings seem to have significantly increased, the Judicial Panel on Multidistrict Litigation (JPML) took a decision to hear the argument of PPI litigations on July 27, 2017, under a new motion to create…

The parent company of Allergan, AbbVie Inc., announced to launch a new awareness campaign to inform women implanted with their recalled Allergan Natrelle…

Another ruling went in favor of the defendant, drug manufacturer Pfizer, for its antidepressant drug Zoloft by a panel of the 3rd U…

A $10 billion class-action opioid lawsuit has been signed by the city of Grande Prairie to become a representative plaintiff against more than 40 pharmaceutical companies. The city…

Taxotere lawsuits' presiding Judge Jane Triche Milazzo passed a defense motion to dismiss the cases filed after December 2015, when new warning labels were added about the…

The FDA has the number of adverse events reported for the Morcellator related cancer incidents have reduced significantly; whereas, the number of …